Brain-derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients

Neurological Sciences

Volumn 22, Issue 6, 2002, Pages 473-474

  Ilzecka, J ^a   Stelmasiak, Z ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; METHIONINE; RECOMBINANT PROTEIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENERVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; MOTONEURON; MUSCLE BIOPSY; NERVE DEGENERATION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; MIDDLE AGED;

EID: 0036224553     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720200009     Document Type: Letter

References (5)

1. Role of neurotrophic factors in neuronal development
2. GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis
3. Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis
4. Evidence that brain derived neurotrophic factor is a trophic factor for motor neurons in vivo
5. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis